CP 461 - An Overview
To mitigate the chance of hypoglycaemia, we sought to extend GK exercise by blocking GKRP. In this article we explain the identification of two strong tiny-molecule GK–GKRP disruptors (AMG-1694 and AMG-3969) that normalized blood glucose ranges in numerous rodent products of diabetic issues. These compounds potently reversed the inhibitory impact